These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7368190)

  • 21. Zinc accumulation in N-methyl-N-nitrosourea-induced rat mammary tumors is accompanied by an altered expression of ZnT-1 and metallothionein.
    Lee R; Woo W; Wu B; Kummer A; Duminy H; Xu Z
    Exp Biol Med (Maywood); 2003 Jun; 228(6):689-96. PubMed ID: 12773700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HRT 2000: pause for thought.
    Harv Womens Health Watch; 2000 Apr; 7(8):1-3. PubMed ID: 10712769
    [No Abstract]   [Full Text] [Related]  

  • 23. [Expert meeting on the effect of sex hormones on the normal breast: moderately increased risk of cancer, but the connection is still not clear].
    von Schoultz B; Bergkvist L; Magnusson C; von Schoultz E
    Lakartidningen; 2000 May; 97(18):2225-6. PubMed ID: 10850053
    [No Abstract]   [Full Text] [Related]  

  • 24. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Shah NR
    Cancer; 2003 Oct; 98(7):1552-3; author reply 1553. PubMed ID: 14508845
    [No Abstract]   [Full Text] [Related]  

  • 25. Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer.
    Antuofermo E; Miller MA; Pirino S; Xie J; Badve S; Mohammed SI
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2247-56. PubMed ID: 17982119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement therapy and breast cancer risk.
    Melnikow J
    J Fam Pract; 1995 Nov; 41(5):501-2. PubMed ID: 7595271
    [No Abstract]   [Full Text] [Related]  

  • 27. Gene expression profiling of NMU-induced rat mammary tumors: cross species comparison with human breast cancer.
    Chan MM; Lu X; Merchant FM; Iglehart JD; Miron PL
    Carcinogenesis; 2005 Aug; 26(8):1343-53. PubMed ID: 15845649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is combined estrogen/progestogen hormone therapy worth the risk?
    Sturdee DW; MacLennan AH
    Climacteric; 2003 Sep; 6(3):177-9. PubMed ID: 14567764
    [No Abstract]   [Full Text] [Related]  

  • 29. A local basis for progesterone action during mammary tumorigenesis - no longer RANK and file.
    Petrie WK; Hovey RC
    Breast Cancer Res; 2011 Jan; 13(1):301. PubMed ID: 21345282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens.
    Naiki-Ito A; Asamoto M; Hokaiwado N; Takahashi S; Yamashita H; Tsuda H; Ogawa K; Shirai T
    Cancer Res; 2007 Dec; 67(23):11353-8. PubMed ID: 18056462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors.
    Rao NA; van Wolferen ME; Gracanin A; Bhatti SF; Krol M; Holstege FC; Mol JA
    J Physiol Pharmacol; 2009 May; 60 Suppl 1():73-84. PubMed ID: 19609016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer and hormone-replacement therapy.
    Wigg DR
    N Engl J Med; 1995 Nov; 333(20):1357; author reply 1357-8. PubMed ID: 7566038
    [No Abstract]   [Full Text] [Related]  

  • 33. Microsatellite instability and loss of heterozygosity on chromosome 10 in rat mammary tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Toyota M; Ushijima T; Weisburger JH; Hosoya Y; Canzian F; Rivenson A; Imai K; Sugimura T; Nagao M
    Mol Carcinog; 1996 Mar; 15(3):176-82. PubMed ID: 8597530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of Ras mutations in rat DMBA-induced mammary tumors.
    Samuelson E; Nilsson J; Walentinsson A; Szpirer C; Behboudi A
    Mol Carcinog; 2009 Feb; 48(2):150-5. PubMed ID: 18649354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On histochemical demonstration of iron in mammary neoplasms in dogs and women].
    Coluzzi G; Calandra P
    Arch Vet Ital; 1965 Feb; 16(1):1-6. PubMed ID: 5858089
    [No Abstract]   [Full Text] [Related]  

  • 36. NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk and lack of overall benefit.
    South Med J; 2002 Aug; 95(8):795-7. PubMed ID: 12190211
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ras gene analysis in mammary tumors of dogs by means of PCR-SSCP and direct genomic analysis].
    Castagnaro M
    Ann Ist Super Sanita; 1995; 31(3):337-41. PubMed ID: 8712577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing the problems of the progestogen.
    Sturdee DW; MacLennan AH
    Climacteric; 2006 Aug; 9(4):241-3. PubMed ID: 16857653
    [No Abstract]   [Full Text] [Related]  

  • 39. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
    Speroff L
    Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The possible effect of diazepam on cancer development and growth.
    Horrobin DF; Trosko JE
    Med Hypotheses; 1981 Jan; 7(1):115-25. PubMed ID: 7207279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.